<html><head><meta name=Title content="Dossier Médical Electronique d’Haiti"><meta name=Keywords content=""><meta http-equiv=Content-Type content="text/html; charset=utf-8"><meta name=ProgId content=Word.Document><meta name=Generator content="Microsoft Word 10"><meta name=Originator content="Microsoft Word 10"><link rel=File-List href="indicatorEN_files/filelist.xml"><title>Dossier Médical Electronique d’Haiti</title><style><!-- /* Font Definitions */@font-face	{font-family:"Times New Roman";	panose-1:0 2 2 6 3 5 4 5 2 3;}@font-face	{font-family:"Courier New";	panose-1:0 2 7 3 9 2 2 5 2 4;}@font-face	{font-family:Wingdings;	panose-1:0 5 2 1 2 1 8 4 8 7;}@font-face	{font-family:Tahoma;	panose-1:0 2 11 6 4 3 5 4 4 2;} /* Style Definitions */p.MsoNormal, li.MsoNormal, div.MsoNormal	{margin:0in;	margin-bottom:.0001pt;	font-size:12.0pt;	font-family:"Times New Roman";}p.BalloonText, li.BalloonText, div.BalloonText	{margin:0in;	margin-bottom:.0001pt;	font-size:8.0pt;	font-family:Tahoma;}span.msoIns	{text-decoration:underline;	text-underline:single;	color:red;}span.msoDel	{text-decoration:line-through;	color:red;}@page Section1	{size:8.5in 11.0in;	margin:1.0in 1.25in 1.0in 1.25in;}div.Section1	{page:Section1;} /* List Definitions */@list l0:level1	{margin-left:69.6pt;	text-indent:-.25in;	tab-stops:list 69.6pt;	font-size:12.0pt;	font-family:Wingdings;}@list l0:level2	{margin-left:75.0pt;	text-indent:-.25in;	tab-stops:list 75.0pt;	font-size:12.0pt;	font-family:Wingdings;}@list l1:level1	{margin-left:.75in;	text-indent:-.25in;	tab-stops:list .75in;	font-family:Wingdings;}@list l2:level1	{margin-left:1.0in;	text-indent:-.25in;	tab-stops:list 1.0in;	font-family:Symbol;}@list l3:level1	{margin-left:.75in;	text-indent:-.25in;	tab-stops:list .75in;	font-family:Wingdings;}@list l4:level1	{margin-left:1.0in;	text-indent:-.25in;	tab-stops:list 1.0in;	font-family:Symbol;}@list l5:level1	{margin-left:1.0in;	text-indent:-.25in;	tab-stops:list 1.0in;	font-family:Symbol;}@list l5:level2	{margin-left:1.5in;	text-indent:-.25in;	tab-stops:list 1.5in;	font-family:"Courier New";}@list l5:level3	{margin-left:2.0in;	text-indent:-.25in;	tab-stops:list 2.0in;	font-family:Wingdings;}@list l5:level4	{margin-left:2.5in;	text-indent:-.25in;	tab-stops:list 2.5in;	font-family:Symbol;}@list l5:level5	{margin-left:3.0in;	text-indent:-.25in;	tab-stops:list 3.0in;	font-family:"Courier New";}@list l5:level6	{margin-left:3.5in;	text-indent:-.25in;	tab-stops:list 3.5in;	font-family:Wingdings;}@list l5:level7	{margin-left:4.0in;	text-indent:-.25in;	tab-stops:list 4.0in;	font-family:Symbol;}@list l5:level8	{margin-left:4.5in;	text-indent:-.25in;	tab-stops:list 4.5in;	font-family:"Courier New";}@list l5:level9	{margin-left:5.0in;	text-indent:-.25in;	tab-stops:list 5.0in;	font-family:Wingdings;}@list l6:level1	{margin-left:1.0in;	text-indent:-.25in;	tab-stops:list 1.0in;	font-family:Symbol;}@list l6:level2	{margin-left:1.5in;	text-indent:-.25in;	tab-stops:list 1.5in;	font-family:"Courier New";}@list l6:level3	{margin-left:2.0in;	text-indent:-.25in;	tab-stops:list 2.0in;	font-family:Wingdings;}@list l6:level4	{margin-left:2.5in;	text-indent:-.25in;	tab-stops:list 2.5in;	font-family:Symbol;}@list l6:level5	{margin-left:3.0in;	text-indent:-.25in;	tab-stops:list 3.0in;	font-family:"Courier New";}@list l6:level6	{margin-left:3.5in;	text-indent:-.25in;	tab-stops:list 3.5in;	font-family:Wingdings;}@list l6:level7	{margin-left:4.0in;	text-indent:-.25in;	tab-stops:list 4.0in;	font-family:Symbol;}@list l6:level8	{margin-left:4.5in;	text-indent:-.25in;	tab-stops:list 4.5in;	font-family:"Courier New";}@list l6:level9	{margin-left:5.0in;	text-indent:-.25in;	tab-stops:list 5.0in;	font-family:Wingdings;}@list l7:level1	{margin-left:66.6pt;	text-indent:-.25in;	tab-stops:list 66.6pt;	font-size:12.0pt;	font-family:Wingdings;}@list l7:level2	{text-indent:-.25in;	tab-stops:list 1.0in;	font-family:"Courier New";}@list l7:level3	{text-indent:-.25in;	tab-stops:list 1.5in;	font-family:Wingdings;}@list l7:level4	{text-indent:-.25in;	tab-stops:list 2.0in;	font-size:12.0pt;	font-family:Symbol;}@list l8:level1	{margin-left:1.0in;	text-indent:-.25in;	tab-stops:list 1.0in;	font-family:Wingdings;}@list l9:level1	{margin-left:1.25in;	text-indent:-.25in;	tab-stops:list 1.25in;	font-size:12.0pt;	font-family:Wingdings;}@list l9:level2	{text-indent:-.25in;	tab-stops:list 1.0in;	font-family:"Courier New";}@list l9:level3	{text-indent:-.25in;	tab-stops:list 1.5in;	font-family:Wingdings;}@list l10:level1	{margin-left:1.0in;	text-indent:-.25in;	tab-stops:list 1.0in;	font-family:Symbol;}@list l10:level2	{margin-left:1.5in;	text-indent:-.25in;	tab-stops:list 1.5in;	font-family:"Courier New";}@list l10:level3	{margin-left:2.0in;	text-indent:-.25in;	tab-stops:list 2.0in;	font-family:Wingdings;}@list l10:level4	{margin-left:2.5in;	text-indent:-.25in;	tab-stops:list 2.5in;	font-family:Symbol;}@list l10:level5	{margin-left:3.0in;	text-indent:-.25in;	tab-stops:list 3.0in;	font-family:"Courier New";}@list l10:level6	{margin-left:3.5in;	text-indent:-.25in;	tab-stops:list 3.5in;	font-family:Wingdings;}@list l10:level7	{margin-left:4.0in;	text-indent:-.25in;	tab-stops:list 4.0in;	font-family:Symbol;}@list l10:level8	{margin-left:4.5in;	text-indent:-.25in;	tab-stops:list 4.5in;	font-family:"Courier New";}@list l10:level9	{margin-left:5.0in;	text-indent:-.25in;	tab-stops:list 5.0in;	font-family:Wingdings;}ol	{margin-bottom:0in;}ul	{margin-bottom:0in;}--></style></head><body bgcolor=white lang=EN-US style='tab-interval:.5in'><div class=Section1><p class=MsoNormal align=center style='text-align:center'><spanstyle='font-size:16.0pt;color:navy'>Quality of Care indicators:</span></p><p class=MsoNormal align=center style='text-align:center'><spanstyle='font-size:16.0pt;color:navy'>Definitions</span></p><p class=MsoNormal><span style='color:navy'><b>&nbsp;</b></span></p><p class=MsoNormal><span style='color:navy'><b>Appropriate Lab Test Indicators</b></span></p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>Ever had test:  </b><span style='font-weight:normal'>Withineach 6 month period, the numerator is the number of patients in the categoriesNew + Active who ever had the test of interest.  The denominator is the totalnumber of patients in the categories New + Active within the same time periods.</span></p><p class=MsoNormal>&nbsp;</p><p class=MsoNormal><b>Up-to-date on test:</b><span style='font-weight:normal'> Within each 6 month period, the numerator is the number of patients in thecategories New + Active who last had the test of interest within the timewindow to meet the standard of care.   The denominator is the total number ofpatients in the categories New + Active within the same time periods.  </span></p><p class=MsoNormal>&nbsp;</p><p class=MsoNormal>The time windows to meet the standard of care are defined asfollows:</p><p class=MsoNormal style='margin-left:.5in'>&nbsp;</p><p class=MsoNormal style='margin-left:.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list .75in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>CD4: </b><span style='font-weight:normal'>For patients on ART,</span><b> </b><spanstyle='font-weight:normal'>CD4 tests should be administered every 6 months, sothe time window to meet the standard of care is 8 months.  The time windowgives a cushion for real-world considerations that might prohibit a patientfrom being tested exactly on the 6-month due date.  For patients in clinicalcare (not on ART), CD4 tests should be administered every 12 months, so thetime window to meet the standard of care is 14 months.  </span></p><p class=MsoNormal style='margin-left:.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list .75in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Liverfunction tests:  </b><span style='font-weight:normal'>For patients on ART,</span><b></b><span style='font-weight:normal'>liver function tests should beadministered every 6 months, so the time window to meet the standard of care is8 months.  For patients in clinical care (not on ART), liver function testsshould be administered every 12 months, so the time window to meet the standardof care is 14 months.  </span></p><p class=MsoNormal style='margin-left:.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list .75in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><b>Hemogram/CBC: </b><span style='font-weight:normal'>For patients both on ART and in clinicalcare, hemograms should be administered every 3 months, so the time window tomeet the standard of care is 5 months.</span></p><p class=MsoNormal style='margin-left:.5in'>&nbsp;</p><p class=MsoNormal><span style='color:navy'><b>Appropriate Treatment Indicators</b></span></p><p class=MsoNormal><span style='color:navy'><b>&nbsp;</b></span></p><p class=MsoNormal><b>ART enrollment among medically eligible: </b><spanstyle='font-weight:normal'>Within each 6 month period, the numerator is the numberof patients in the categories New + Active newly meeting criteria forenrollment on ART who received ART dispensed within 3 months of meetingcriteria.  The denominator is the total the number of patients in thecategories New + Active newly meeting criteria for enrollment on ART within thesame time periods.</span></p><p class=MsoNormal>&nbsp;</p><p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt'>Medical eligibility criteria for ARTenrollment are:</p><p class=MsoNormal style='margin-left:1.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.75in;text-autospace:none'><spanlang=FR style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=FR>CD4&lt;200&nbsp;: Drawn from <i>Compte CD4</i></span><spanlang=FR> section of the <i>Fiche de la Premiere Visite Clinique</i></span><spanlang=FR>, or <i>Résultats</i></span><span lang=FR> section in the <i>Fiched’Analyses de Laboratoire</i></span><span lang=FR>.</span></p><p class=MsoNormal style='margin-left:1.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.75in;text-autospace:none'><spanlang=FR style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=FR>TLC&lt;1200&nbsp;: Drawn from <i>Résultats</i></span><spanlang=FR> section in the <i>Fiche d’Analyses de Laboratoire</i></span><spanlang=FR>.</span></p><p class=MsoNormal style='margin-left:1.75in;text-autospace:none'><spanlang=FR>&nbsp;</span></p><p class=MsoNormal style='margin-left:1.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.75in;text-autospace:none'><spanlang=FR style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=FR>OMS Stade III+CD4&lt;350&nbsp;: CD4 data drawn from<i>Compte CD4</i></span><span lang=FR> section of the <i>Fiche de la PremiereVisite Clinique</i></span><span lang=FR>, or <i>Résultats</i></span><spanlang=FR> section in the <i>Fiche d’Analyses de Laboratoire&nbsp;; </i></span><spanlang=FR>WHO Stage data drawn from <i>Antécedents Médicaux et DiagnosticsActuels</i></span><span lang=FR> sections of clinical visit forms.</span></p><p class=MsoNormal style='margin-left:1.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.75in;text-autospace:none'><spanlang=FR style='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span><span lang=FR>OMS Stade IV&nbsp;: WHO Stage data drawn from <i>AntécedentsMédicaux et Diagnostics Actuels</i></span><span lang=FR> sections of clinicalvisit forms.</span></p><p class=MsoNormal style='margin-left:1.75in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.75in;text-autospace:none'><spanstyle='font-family:Wingdings'>§<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span>PTME&nbsp;; Medical Elegibility established at previous visit&nbsp;;Previous Tritherapy &nbsp;; Prophylaxie post-exposition (PEP)&nbsp;: Drawn frommedical eligibility question checklist at the end of clinical intake and clinicalfollow-up forms.</p><p class=MsoNormal style='text-autospace:none'>&nbsp;</p><p class=MsoNormal>&nbsp;</p><p class=MsoNormal><b>Cotrimoxizole prophylaxis among medically eligible: </b><spanstyle='font-weight:normal'>Within each 6 month period, the numerator is the numberof patients in the categories New + Active newly meeting criteria for Cotrimoxizoleprophylaxis for whom this medication was dispensed within 3 months of meetingcriteria.  The denominator is the total the number of patients in thecategories New + Active newly meeting criteria for Cotrimoxizole prophylaxiswithin the same time periods.</span></p><p class=MsoNormal>&nbsp;</p><p class=MsoNormal style='margin-left:.5in'>For patients on ART, the criteriafor Cotrimoxizole prophylaxis are:</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>AnyCD4 test result of less than 200 </p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Diagnosisof thrush (muguet) in the past 6 months</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Diagnosisof Oesophagites dûe à candidose in the past 6 months</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>OMSStage IV </p><p class=MsoNormal style='margin-left:.5in;tab-stops:0in'>&nbsp;</p><p class=MsoNormal style='margin-left:.5in'>For patients in clinical care(never started on ART), the criteria for Cotrimoxizole prophylaxis are:</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>AnyCD4 test result of less than 200 in the past 6 months </p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Anydiagnosis of thrush (muguet) at any point in the past</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Anydiagnosis of Oesophagites dûe à candidose at any point in the past</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642;tab-stops:list 1.5in'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>OMSStage IV </p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>Continuation Cotrimoxizole prophylaxis: </b><spanstyle='font-weight:normal'>Within each 6 month period, the numerator is the numberof patients in the categories New + Active newly started on Cotrimoxizolewithin the time window, with at least 1 dispense of Cotrimoxizole within last 2months of 6 month interval.  The denominator is the total the number ofpatients in the categories New + Active newly started on Cotrimoxizoleprophylaxis within the same time periods.</span></p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>TB treatment among medically eligible: </b><spanstyle='font-weight:normal'>Within each 6 month period, the numerator is the numberof patients in the categories New + Active newly meeting criteria for TBtreatment with any 4 of 5 TB drugs (Ethambutol, Isoniazide,</span><spanstyle='font-size:9.0pt'> </span>Pyrazinamide, Rifampicine, Streptomycine)dispensed within 3 months of meeting criteria.  The denominator is the totalthe number of patients in the categories New + Active newly meeting criteriafor TB treatment within the same time periods.</p><p class=MsoNormal>&nbsp;</p><p class=MsoNormal style='margin-top:6.0pt;margin-right:0in;margin-bottom:0in;margin-left:.5in;margin-bottom:.0001pt'>Criteria for TB treatment are:</p><p class=MsoNormal style='margin-left:1.0in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>AbnormalPPD result, plus one or more of the following:</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Sputumtest done with abnormal findings</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>ChestX-Ray done with abnormal findings</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Diagnosisof TB (both pulmonary and extrapulmonary/disseminated TB diagnoses areconsidered)</p><p class=MsoNormal style='margin-left:1.5in;text-indent:-.25in;mso-list-change:§ Fabienne 20070525T1642'><span style='font-family:Wingdings'>§<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Clinicalpresentation of TB, defined by:</p><p class=MsoNormal style='margin-left:2.0in;text-indent:-.25in;mso-list-change:· Fabienne 20070525T1642;tab-stops:list 2.0in'><span style='font-family:Symbol'>·<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Cough&gt; 3 weeks AND Night sweats AND Fever</p><p class=MsoNormal style='margin-left:1.75in'>OR</p><p class=MsoNormal style='margin-left:2.0in;text-indent:-.25in;mso-list-change:· Fabienne 20070525T1642;tab-stops:list 2.0in'><span style='font-family:Symbol'>·<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Coughwith expectoration AND Night sweats AND Fever</p><p class=MsoNormal style='margin-left:1.75in'>OR</p><p class=MsoNormal style='margin-left:2.0in;text-indent:-.25in;mso-list-change:· Fabienne 20070525T1642;tab-stops:list 2.0in'><span style='font-family:Symbol'>·<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>HemoptysieAND Night sweats AND Fever </p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>Continuation TB treatment: </b><span style='font-weight:normal'>Within each 6 month period, the numerator is the number of patients inthe categories New + Active newly started on TB treatment within the time window,with at least 1 dispense of at least 2 TB medications within last 2 months of 6month interval.  The denominator is the total the number of patients in thecategories New + Active newly started on TB treatment within the same timeperiods.</span></p><p class=MsoNormal><br>&nbsp;&nbsp;<br><span style='color:navy'><b>Incident Disease and Death Reports</b></span></p><p class=MsoNormal><span style='color:navy'><b>&nbsp;</b></span></p><p class=MsoNormal><b>First diagnosis of PCP among active patients:  </b><spanstyle='font-weight:normal'>Within each 6 month period, the numerator is the numberof patients in the categories New + Active who received a first diagnosis ofPCP within the time window.  The first diagnosis date must fall after theirclinical intake visit date.  The denominator is the number of patients in thecategories New + Active within the same time periods.</span></p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>First diagnosis of TB among active patients:  </b><spanstyle='font-weight:normal'>Within each 6 month period, the numerator is the numberof patients in the categories New + Active who received a first diagnosis of TB(pulmonary or extrapulmonary/disseminated TB) within the time window.  Thefirst diagnosis date must fall after their clinical intake visit date.  Thedenominator is the number of patients in the categories New + Active within thesame time periods.</span></p><p class=MsoNormal><b>&nbsp;</b></p><p class=MsoNormal><b>Deaths by year:  </b><span style='font-weight:normal'>Thenumber of patients with discontinuation report completed with death listed asreason for discontinuation.  If no date of death is recorded on thediscontinuation report, the date considered will be the earliest of thefollowing dates:</span></p><p class=MsoNormal style='margin-left:2.0in;text-indent:-.25in;mso-list-change:· Fabienne 20070525T1642;tab-stops:list 2.0in'><span style='font-family:Symbol'>·<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Recordeddate for last patient contact</p><p class=MsoNormal style='margin-left:2.0in;text-indent:-.25in;mso-list-change:· Fabienne 20070525T1642;tab-stops:list 2.0in'><span style='font-family:Symbol'>·<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Recordeddate for discontinuation from the HIV care and treatment program</p><p class=MsoNormal style='margin-left:2.0in;text-indent:-.25in;mso-list-change:· Fabienne 20070525T1642;tab-stops:list 2.0in'><span style='font-family:Symbol'>·<spanstyle='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span>Dateof the Discontinuation Report</p></div></body></html>